Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2018 Jul;24(7):865-867.
doi: 10.1002/lt.25203.

Asprin and statin use for management of atherosclerotic cardiovascular disease in liver transplant candidates: Are we missing the mark?

Lisa B VanWagner  1   2
Affiliations
Editorial

Asprin and statin use for management of atherosclerotic cardiovascular disease in liver transplant candidates: Are we missing the mark?

Lisa B VanWagner. Liver Transpl. 2018 Jul.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest Statement: I have no pertinent conflicts of interest.

Comment on

References

    1. Kim WR, Lake JR, Smith JM, Skeans MA, Schladt DP, Edwards EB, Harper AM, et al. OPTN/SRTR 2013 Annual Data Report: liver. Am J Transplant 2015;15 Suppl 2:1–28. - PubMed
    1. Fussner LA, Heimbach JK, Fan C, Dierkhising R, Coss E, Leise MD, Watt KD. Cardiovascular disease after liver transplantation: When, What, and Who Is at Risk. Liver Transpl 2015;21:889–896. - PubMed
    1. VanWagner LB, Serper M, Kang R, Levitsky J, Hohmann S, Abecassis M, Skaro A, et al. Factors Associated With Major Adverse Cardiovascular Events After Liver Transplantation Among a National Sample. Am J Transplant 2016;16:2684–2694. - PMC - PubMed
    1. Patel SS, Nabi E, Guzman L, Abbate A, Bhati C, Stravitz RT, Reichman T, et al. Coronary artery disease in decompensated patients undergoing liver transplantation evaluation. Liver Transpl 2018;24:333–342. - PubMed
    1. VanWagner LB, Harinstein ME, Runo JR, Darling C, Serper M, Hall S, Kobashigawa JA, et al. Multidisciplinary approach to cardiac and pulmonary vascular disease risk assessment in liver transplantation: An evaluation of the evidence and consensus recommendations. Am J Transplant 2018;18:30–42. - PMC - PubMed

Substances